Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome) Overview

Save information for later
Sign Up

Learn About Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)

View Main Condition: Mucopolysaccharidoses (MPS)

What is the definition of Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)?
Mucopolysaccharidosis type IV (MPS IV), also known as Morquio syndrome, is a rare metabolic condition in which the body is unable to break down long chains of sugar molecules called glycosaminoglycans. As a result, toxic levels of these sugars accumulate in cell structures called lysosomes, leading to the various signs and symptoms associated with the condition. These signs and symptoms may include abnormalities of the skeleton, eyes, heart and respiratory system. There are two forms of MPS IV. MPS IVA is caused by changes in the GALNS gene. MPS IVB is caused by genetic changes in the GLB1 gene. Both forms are inherited in an autosomal recessive manner.
What are the alternative names for Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)?
  • Mucopolysaccharidosis type IV
  • MPS4
  • MPSIV
  • Morquio disease
  • Mucopolysaccharidosis type 4
What are the different types of Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)?
Who are the top Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome) Local Doctors?
Experienced in Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Medical Genetics | Pediatrics
Experienced in Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Medical Genetics | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (207.6 mi)
Languages Spoken:
English

Robert Hopkin is a Medical Genetics specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Hopkin and is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome). His top areas of expertise are Fabry Disease, Micrognathia, Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant, and Multiple Sulfatase Deficiency.

 
 
 
 
Learn about our expert tiers
Learn More
What are the latest Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome) Clinical Trials?
Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect

Summary: Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life. Baby Detect Project is an innovative NBS program using a pane...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Mucopolysaccharidosis Patients in France in the Era of Specific Therapeutics

Summary: The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center